Invited Speakers (Preliminary List)

Home/Invited Speakers (Preliminary List)
Invited Speakers (Preliminary List) 2017-03-23T14:54:39+00:00

Dr. Martine Rothblatt, Ph.D.
CEO, United Therapeutics, Silver Spring, MD, USA

Shmuel (Mooly) Eden
Former Intel Senior Vice President and President Intel Israel,
Chairman, University of Haifa, Haifa

Dr. Gil Bar Nahum, Ph.D.
Managing Director at Jefferies International, London, UK

Deborah DiSanzo
General Manager, IBM Watson Health, Cambridge, MA, USA

Prof. Nir Barzilai, M.D.
Albert Einstein College of Medicine, New York City, NY, USA

Dr. Lloyd Klickstein, M.D. Ph.D.
Head of Translational Medicine, New Indications Discovery Unit
Novartis Institutes for BioMedical Research,
Novartis, Cambridge, MA, USA

Prof. Yuval Dor, M.D.
Hadassah Hebrew University, Jerusalem

Prof. Gal Markel, M.D. Ph.D.
Sheba Medical Center, Ramat Gan

Dr. Mark D.  Stovsky, M.D. MBA
Cleveland Clinic Ventures and Cleveland Clinic Innovations, Cleveland, OH, USA

Dr. Allan S. Jaffe, M.D.
Mayo Clinic, Rochester, MN, USA

Dr. Iris Grossman, Ph.D.
Vice President, Head of Personalized & Predictive Medicine, Analytics and Big Data (PPM-ABD), Global R&D at Teva Pharmaceuticals

Prof. Michal Beeri, Ph.D.
Sheba Medical Center, Ramat Gan

Dr. Ilana Schlesinger, M.D.
Rambam Medical Center, Haifa

Dr. Fredric B. Meyer, M.D.
Mayo Clinic, Rochester, MN, USA

Dr. Shai Efrati, M.D.
Assaf Harofeh Medical Center, Tzrifin

Dr. Shahar Arzy, M.D. Ph.D.
Hadassah Medical Center, Jerusalem

Prof. Shlomo Noy, M.D.
Sheba Medical Center, Ramat Gan

Prof. Tzvi Dwolatzky, M.D. Ph.D.
Rambam Medical Center, Haifa

Steven E. Cohen, M.D.
Executive Director | External Scientific Affairs, Cardiovascular-Metabolism & Internal Medicine, Global Cardiovascular-Metabolic Therapeutic Area, Daiichi Sankyo, Inc, USA

Esther Lukasiewics Hagai, M.D. Ph.D.
VP Medical & Clinical Affairs, Pluristem Ltd.

Ora Dar
Israel Innovation Authority

 

Charles Kessler, Ph.D.
Principal Scientific Officer, DG Research & Innovation, Health-E5, European Commission

Jim Knight
Senior Vice President, Head of Corporate Development, BioTime, Inc.

Zami Aberman
CEO, Pluristem Therapeutics Inc.

Prof. Gal A. Kaminka, Ph.D.
Bar-Ilan University, Ramat Gan

Dr. Goren Gordon, Ph.D.
Tel Aviv University, Tel Aviv

Prof. Alon Wolf, Ph.D,
Technion Institute of Technology, Haifa

Prof. Yael Idan, Ph.D.
Ben Gurion University of the Negev, Beer Sheva

Prof. Tamar Weiss, Ph.D.
University of Haifa, Haifa

Prof. Sigal Berman, Ph.D.
Ben Gurion University of the Negev, Beer Sheva

Prof. Tal Oron-Gilad, Ph.D.
Ben Gurion University of the Negev, Beer Sheva

Prof. Dario Liebermann, Ph.D.
Tel Aviv University, Tel Aviv

Dr. Maja Rudinac, Ph.D.
CEO, Robot Care Systems, The Hague Area, Netherlands

Dor Skuler
CEO, Intuition Robotics, Ramat Gan

Prof. Filippo Cavallo, Ph.D.
The BioRobotics Institute, Scuola Superiore Sant’Anna, Pisa, Italy

Prof. Amir Lerman, M.D.
Mayo Clinic, Rochester, MN, USA

Prof. Lior Gepstein, M.D. Ph.D.
Technion Institute of Technology, Haifa

Prof. Haim Danenberg, M.D.
Hadassah Medical Center, Jerusalem

Prof. Rafi Beyar, M.D. Ph.D.
Rambam Medical Center, Haifa

Prof. Dror Harats, M.D.
Sheba Medical Center, Ramat Gan

Prof. Steve Austad, Ph.D.
University of Alabama, Tuscaloosa, AL, USA

Prof. Haim Cohen, Ph.D.
Bar-Ilan University, Ramat Gan

Prof. James Kirkland, M.D. Ph.D.
Mayo Clinic, Rochester, MN, USA

Prof. Nir Barzilai, M.D.
Albert Einstein College of Medicine, New York City, NY, USA